patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
esketamine
Phase 2updated 2mo agoby Bioron Pharma🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for major depressive disorder and 10 investigational indications.
indications
indications
Major Depression
targets
Glutamate [NMDA] receptor
all catalysts(2)
phase 0 trial completion · 1
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that